Barrier Therapeutics Inc. Resources | BNET
On CHOW: Does drinking ice water burn calories?

BNET Industries

Barrier Therapeutics Inc. (BTRX) is in the Pharma Industry

Revenue
Dec 31 2007
$24.0M
Profit
Dec 31 2007
($53.6M)
Market Cap
Jul 02 2008
$141.2M

Latest News and Analysis

  • Wall Street News Alert: Breaking News Alert - NTRO! June 24, 2008

    Wall Street News Alert's "stocks to watch" thismorning are: Nitro Petroleum, Inc. (OTCBB: NTRO), ConocoPhillips (NYSE: COP), Barrier Therapeutics, Inc. (NASDAQ: BTRX) and Corn ProductsInternational, Inc. (NYSE: CPO). Nitro Petroleum, Inc. (OTCBB: NTRO) continues to make progress, and thecompany should be a "must see" for investors looking to possibly benefitfrom...

    Articles 2008-06-24

  • Story Stock for Tuesday, June 24, 2008: NPHS Summer Sales Growth!

    TheSUBWAY.com announces the following stocks toits Action List: NextPhase Wireless (OTCBB: NPHS), Barrier Therapeutics,Inc. (NASDAQ: BTRX), Royale Energy, Inc. (NASDAQ: ROYL), Level 3Communications, Inc. (NASDAQ: LVLT). Visit TheSUBWAY's Small Cap Investor Forum Here: http://investor-forum.thesubway.com/ NextPhase Wireless, Inc. (OTCBB: NPHS), a nationwide developer ofWiMAX-ready networks and provider of advanced...

    Articles 2008-06-24

  • BeaconEquity.com Issues TraderNotes on Active Stocks: NLN, GRVY, MDTL, ENER, BTRX, MNKD, ALTI, BG

    DALLAS, June 24 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/ Today's TraderNotes include: National Lampoon Incorporated , Gravity Co. Ltd. , Medis...

    Articles 2008-06-24

  • Barrier Therapeutics to Merge Into Stiefel Laboratories

    Acquisition to enhance industry leader's dermatological portfolio CORAL GABLES, Fla., June 23 /PRNewswire/ -- Stiefel Laboratories Inc., the world's largest independent pharmaceutical company specializing in dermatology, today announced it has signed a definitive merger agreement, pursuant to which Stiefel Laboratories will acquire Barrier Therapeutics, Inc. ("Barrier Therapeutics")...

    Articles 2008-06-23

  • BellwetherReport.com Analyst Report on BTRX, SOHU, ENER and GTCB

    BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

    Articles 2008-06-23

  • Incorporated: 2001
  • CEO: Mr. Alfred Altomari
  • Employees: 130

Barrier Therapeutics is a pharmaceutical company focused on the development and commercialization of pharmaceutical products in the field of dermatology. As of Dec 31 2007, Co. marketed three pharmaceutical products, namely Vusion®, Xolegel® and Solagé® in the U.S. Co. also has product candidates in various stages of clinical development including Hyphanox™, Pramiconazole, Oral Rambazole™, Topical Rambazole and Hivenyl for the treatment of a range of dermatological conditions, including onychomycosis, psoriasis, acne, skin allergies and superficial fungal infections. Co. markets its products to dermatologists and other target physicians via its sales force and co-promotion agreement.

Key Competitors

advertisement
Barrier Therapeutics Inc. Company Info

Board of Directors

Mr. Peter Ernster

Chairman

Mr. Alfred Altomari

Dr. Geert Cauwenbergh Ph.D.

Dr. Srinivas Akkaraju Ph.D.

Mr. Robert E. Campbell

Mr. Edward L. Erickson

Dr. Carl W. Ehmann M.D.

Mr. Charles F. Jacey Jr.

Ms. Carol Raphael

Contact Information

600 College Road East,

Suite 3200

Princeton, NJ

http://www.barriertherapeutics.com

609 945-1200

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement